Puma Biotechnology, Inc., a biopharmaceutical company, announced on September 2, 2025, that its Compensation Committee has approved the grant of restricted stock unit awards for four new non-executive employees. The awards cover a total of 25,750 shares of Puma common stock and are part of the company's 2017 Employment Inducement Incentive Award Plan. These stock units are set to vest over a three-year period, with one-third vesting on the first anniversary of the award's commencement date and the remaining shares vesting in installments every six months thereafter.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250904770760) on September 04, 2025, and is solely responsible for the information contained therein.